Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee postal kits for home collection

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

Novosanis research grant

30/06/2021
Novosanis is offering a research grant in collaboration with EACR to stimulate innovative research in cancer biomarker detection using urine as a sample type. Urine can be collected in an easy, quick and non-invasive way, and has shown potential to change the way cancer is detected and monitored...
Read more

Latest blogpost

View all blogs

Urine as an emerging liquid biopsy for prostate cancer biomarker detection

Urine as an emerging liquid biopsy for prostate cancer biomarker detection

14/06/2021
Current methods for PCa detection lack specificity Prostate cancer (PCa) is the second most frequently diagnosed cancer and a major cause of death in men worldwide. Testing for prostate-specific antigen (PSA) in blood, the current gold standard for PCa screening has limitations. Other non-cancerous...
Read more

Upcoming event

There are no events associated with this category.